Literature DB >> 27316720

β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.

Shreesh Ojha1, Hayate Javed2, Sheikh Azimullah1, M Emdadul Haque3.   

Abstract

Parkinson disease (PD) is a neurodegenerative disease characterized by progressive dopaminergic neurodegeneration in the substantia nigra pars compacta (SNc) area. The present study was undertaken to evaluate the neuroprotective effect of β-caryophyllene (BCP) against rotenone-induced oxidative stress and neuroinflammation in a rat model of PD. In the present study, BCP was administered once daily for 4 weeks at a dose of 50 mg/kg body weight prior to a rotenone (2.5 mg/kg body weight) challenge to mimic the progressive neurodegenerative nature of PD. Rotenone administration results in oxidative stress as evidenced by decreased activities of superoxide dismutase, catalase, and depletion of glutathione with a concomitant rise in lipid peroxidation product, malondialdehyde. Rotenone also significantly increased pro-inflammatory cytokines in the midbrain region and elevated the inflammatory mediators such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in the striatum. Further, immunohistochemical analysis revealed loss of dopaminergic neurons in the SNc area and enhanced expression of ionized calcium-binding adaptor molecule-1 (Iba-1) and glial fibrillary acidic protein (GFAP), indicators of microglia activation, and astrocyte hypertrophy, respectively, as an index of inflammation. However, treatment with BCP rescued dopaminergic neurons and decreased microglia and astrocyte activation evidenced by reduced Iba-1 and GFAP expression. BCP in addition to attenuation of pro-inflammatory cytokines and inflammatory mediators such as COX-2 and iNOS, also restored antioxidant enzymes and inhibited lipid peroxidation as well as glutathione depletion. The findings demonstrate that BCP provides neuroprotection against rotenone-induced PD and the neuroprotective effects can be ascribed to its potent antioxidant and anti-inflammatory activities.

Entities:  

Keywords:  Neurodegeneration; Neurotoxicity; Parkinson disease; Rotenone; β-Caryophyllene

Mesh:

Substances:

Year:  2016        PMID: 27316720     DOI: 10.1007/s11010-016-2733-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  43 in total

Review 1.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation.

Authors:  Mireille Bélanger; Igor Allaman; Pierre J Magistretti
Journal:  Cell Metab       Date:  2011-12-07       Impact factor: 27.287

2.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

Review 3.  Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease.

Authors:  Juliet M Taylor; Bevan S Main; Peter J Crack
Journal:  Neurochem Int       Date:  2013-01-04       Impact factor: 3.921

Review 4.  Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?

Authors:  Ju-Xian Song; Stephen Cho-Wing Sze; Tzi-Bun Ng; Caivin Kai-Fai Lee; George P H Leung; Pang-Chui Shaw; Yao Tong; Yan-Bo Zhang
Journal:  J Ethnopharmacol       Date:  2011-12-29       Impact factor: 4.360

5.  Antigenotoxic capacity of beta-caryophyllene in mouse, and evaluation of its antioxidant and GST induction activities.

Authors:  Isela Alvarez-González; Eduardo Madrigal-Bujaidar; Seydi Castro-García
Journal:  J Toxicol Sci       Date:  2014       Impact factor: 2.196

Review 6.  Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease.

Authors:  J P Little; E B Villanueva; A Klegeris
Journal:  Mini Rev Med Chem       Date:  2011-06       Impact factor: 3.862

7.  β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.

Authors:  Hong-Ik Cho; Jeong-Min Hong; Joo-Wan Choi; Hyo-Sun Choi; Jong Hwan Kwak; Dong-Ung Lee; Sang Kook Lee; Sun-Mee Lee
Journal:  Eur J Pharmacol       Date:  2015-08-05       Impact factor: 4.432

8.  β-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway.

Authors:  L C Assis; M R Straliotto; D Engel; M A Hort; R C Dutra; A F de Bem
Journal:  Neuroscience       Date:  2014-09-04       Impact factor: 3.590

Review 9.  The emerging role of nutrition in Parkinson's disease.

Authors:  Stacey E Seidl; Jose A Santiago; Hope Bilyk; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2014-03-07       Impact factor: 5.750

10.  Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.

Authors:  Shreesh Ojha; Hayate Javed; Sheikh Azimullah; Salema B Abul Khair; M Emdadul Haque
Journal:  Drug Des Devel Ther       Date:  2015-10-07       Impact factor: 4.162

View more
  39 in total

1.  The cannabinoid receptor 2 agonist, β-caryophyllene, improves working memory and reduces circulating levels of specific proinflammatory cytokines in aged male mice.

Authors:  Lindsey Phillips Lindsey; Cedrick Maceo Daphney; Aboagyewaah Oppong-Damoah; Peter Nikolaevich Uchakin; Sarah E Abney; Olga N Uchakina; Richard Darien Khusial; Ayman Akil; Kevin Sean Murnane
Journal:  Behav Brain Res       Date:  2019-06-04       Impact factor: 3.332

2.  Enzymes that hydrolyze adenine nucleotides in a model of hypercholesterolemia induced by Triton WR-1339: protective effects of β-caryophyllene.

Authors:  Matheus D Baldissera; Carine F Souza; Pedro H Doleski; Daniela B R Leal; Lenita M Stefani; Aline A Boligon; Silvia G Monteiro
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

Review 3.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

4.  GPR30 Activation Contributes to the Puerarin-Mediated Neuroprotection in MPP+-Induced SH-SY5Y Cell Death.

Authors:  Yue-Fa Cheng; Guoqi Zhu; Qing-Wen Wu; Yue-Sheng Xie; Yan Jiang; Lan Guo; Ya-Li Guan; Ying-Shuo Liu; Jun Zhang
Journal:  J Mol Neurosci       Date:  2016-10-30       Impact factor: 3.444

Review 5.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

Review 6.  Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Authors:  Nilson Carlos Ferreira Junior; Maurício Dos-Santos-Pereira; Francisco Silveira Guimarães; Elaine Del Bel
Journal:  Neurotox Res       Date:  2019-10-22       Impact factor: 3.911

7.  Does β-caryophyllene protect against renal dysfunction following ischemia-reperfusion injury in the rat?

Authors:  Fayez T Hammad; Shreesh Ojha; Shamsulislam Azimullah; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-12-25

8.  β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.

Authors:  Zoltan V Varga; Csaba Matyas; Katalin Erdelyi; Resat Cinar; Daniela Nieri; Andrea Chicca; Balazs Tamas Nemeth; Janos Paloczi; Tamas Lajtos; Lukas Corey; Gyorgy Hasko; Bin Gao; George Kunos; Jürg Gertsch; Pal Pacher
Journal:  Br J Pharmacol       Date:  2017-02-22       Impact factor: 8.739

9.  Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases.

Authors:  Catalina Pérez-Olives; Rafael Rivas-Santisteban; Jaume Lillo; Gemma Navarro; Rafael Franco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats.

Authors:  Matheus D Baldissera; Carine F Souza; Thirssa H Grando; Pedro H Doleski; Aline A Boligon; Lenita M Stefani; Silvia G Monteiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.